Novel Regenerative Treatment of TBI and Post TBI Depression
Novel Regenerative Treatment of TBI and Post TBI Depression
批准号:
10623171
负责人:
Shan P. Yu
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-01-01 至 2023-03-31
关键词:
AccidentsAcuteAreaAstrocytesAthletic InjuriesAttenuatedAutologousAxonBehaviorBehavioralBrainBrain InjuriesBrain-Derived Neurotrophic FactorBypassCell TherapyCell TransplantationCellsChemicalsChronicChronic PhaseCicatrixCombined Modality TherapyContusionsDataDevelopmentEctopic ExpressionExerciseGene ExpressionGene Expression RegulationGenesGliosisGoalsHealthIn VitroInjectionsInjuryInvestigationLentivirus VectorLesionMental DepressionMental disordersMitoticModelingMusNatural regenerationNeurogliaNeuronal PlasticityNeuronsNeuroprotective AgentsOxytocinPatientsPharmacotherapyPhysiologicalPluripotent Stem CellsPost-Traumatic Stress DisordersRecovery of FunctionRegenerative MedicineRehabilitation therapyReportingResearchRiskSignal TransductionSiteSoldierSomatic CellSourceSpinal cord injuryStem cell transplantTBI PatientsTBI treatmentTestingTherapeuticTherapeutic EffectTissuesTransplantationTraumatic Brain InjuryUp-RegulationVeteransWaradult neurogenesisastrogliosisaxon growthaxon regenerationbasebehavior testbrain tissuecell typecentral nervous system injurychronic depressionclinical translationcombatcontrolled cortical impactdelivery vehicledisabilityeffective therapyexperimental studyimprovedin vivomiddle agemouse modelnerve stem cellneural networkneurogenesisneurovascular injurynovelnovel therapeuticspreventprotective effectpsychologicreconstructionregenerativeregenerative treatmentrepairedsexstroke therapysubventricular zonesuccesssynaptogenesistissue repairtranscription factortreadmilltumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
As soldiers are returning from wars around the globe, traumatic brain injury (TBI) has been reported
among veterans. Brain structural damage of different degrees and functional/behavioral deficits such
as post-traumatic stress disorder (PTSD) including post-TBI depression (PTD) are frequently seen
among these patients. So far, there is basically no effective treatment for acute TBI or chronic
patients. In recent years, cell-based therapy provides an attractive and coherent approach in
regenerative medicine. Based on the latest advancement and our preliminary data, we propose a
novel delayed treatment by directly converting endogenous astrocytes accumulated around the injury
site into "induced neurons (iNs)" in the chronic phase after TBI. In a mild/moderate TBI mouse model,
the direct reprogramming gene NeuroD1 (ND1) that targets reactive astrocytes will be expressed in
the peri-contusion region by lentiviral injection. We hypothesize that the intra-lineage direct
reprogramming provides a viable endogenous source of new neurons by leveraging existing
proliferative astrocytes after TBI and helps to prevent the development of PTD (Specific Aim 1). We
propose that the reprogramming gene expression will effectively reduce gliosis or glial scar formation
during the chronic phase after TBI, which will lessen physical and chemical barriers for regeneration
and significantly facilitate axonal outgrowth and other regenerative activities (Aim 2). It is further
hypothesized that combined rehabilitation of treadmill exercise will improve ND1-induced gene
regulation, post-TBI tissue repair and functional activities (Aim 3). We propose that, in the combination
therapy, iNs arisen within the host tissue enriched by up-regulated genes such as BDNF and oxytocin
are conducive to integration with existing neural networks. Our preliminary data demonstrate the
feasibility of converting astrocytes into mature neurons, increased regenerative/behavioral genes, and
improved psychological behaviors chronically after TBI. The goal of this investigation is to
demonstrate and develop an effective treatment for veteran patients with TBI-related PTD.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Innovative memantine therapy for neuroprotective effects against ischemic stroke and Alzheimer's disease
-
批准号:10480182
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Shan P. Yu
-
依托单位:
The role of NMDA receptor subunit GluN3A in age and Alzheimer's disease-related dementia
-
批准号:10491045
-
项目类别:
-
资助金额:$19.56万
-
财政年份:2021
-
负责人:Shan P. Yu
-
依托单位:
Novel Regenerative Treatment of TBI and Post TBI Depression
-
批准号:10385693
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Shan P. Yu
-
依托单位:
Novel Regenerative Treatment of TBI and Post TBI Depression
-
批准号:10060751
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Shan P. Yu
-
依托单位:
Protection of the Brain by Chemical Hypothermia
-
批准号:8485302
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Shan P. Yu
-
依托单位:
Protection of the Brain by Chemical Hypothermia
-
批准号:8998977
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Shan P. Yu
-
依托单位:
Protection of the Brain by Chemical Hypothermia
-
批准号:8990783
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Shan P. Yu
-
依托单位:
Neuroprotection NR3A in Cultured Neurons and Ischemic Neonates
-
批准号:7321490
-
项目类别:
-
资助金额:$25.55万
-
财政年份:2007
-
负责人:Shan P. Yu
-
依托单位:
Neuroprotection NR3A in Cultured Neurons and Ischemic Neonates
-
批准号:7798147
-
项目类别:
-
资助金额:$26.85万
-
财政年份:2007
-
负责人:Shan P. Yu
-
依托单位:
Neuroprotection NR3A in Cultured Neurons and Ischemic Neonates
-
批准号:7999235
-
项目类别:
-
资助金额:$26.58万
-
财政年份:2007
-
负责人:Shan P. Yu
-
依托单位:
Neuroprotection NR3A in Cultured Neurons and Ischemic Neonates
-
批准号:7485805
-
项目类别:
-
资助金额:$27.13万
-
财政年份:2007
-
负责人:Shan P. Yu
-
依托单位:
海外基金